A new
gene1 (mcr-1) that enables bacteria to be highly
resistant2 to polymyxins, the last line of
antibiotic3 defence we have left, is widespread in Enterobacteriaceae [1] taken from pigs and patients in south China, including strains with
epidemic4 potential, according to new research published in The Lancet Infectious Diseases. The mcr-1 gene was found on plasmids, mobile
DNA5 that can be easily copied and transferred between different bacteria, suggesting an alarming potential to spread and
diversify6 between different
bacterial7 populations.
"These are extremely worrying results. The polymyxins (colistin and polymyxin B) were the last class of
antibiotics8 in which resistance was
incapable9 of spreading from cell to cell. Until now, colistin resistance resulted from
chromosomal10 mutations, making the resistance
mechanism11 unstable12 and incapable of spreading to other bacteria,"[2] explains author Professor Jian-Hua Liu from South China Agricultural University in Guangzhou, China.
"Our results reveal the
emergence13 of the first polymyxin resistance gene that is readily passed between common bacteria such as Escherichia coli and Klesbsiella pneumoniae, suggesting that the progression from extensive drug resistance to pandrug resistance is
inevitable14."[2]
During routine testing of food animals for antimicrobial resistance in China, Liu and colleagues
isolated15 an E coli strain (SHP45) from a pig on an intensive pig farm in Shanghai that showed resistance to colistin that could be transferred to another strain. This prompted the researchers to collect bacteria samples from pigs at
slaughter16 across four provinces, and from pork and chicken sold in 30 open markets and 27 supermarkets across Guangzhou between 2011 and 2014. They also analysed bacteria samples from patients presenting with infections to two hospitals in Guangdong and Zhejiang provinces. Samples were tested for antibiotic susceptibility and the mcr-1 gene using polymerase chain reaction (PCR) and sequencing.